DIFFUSIO2N Trademark

Trademark Overview

On Wednesday, September 24, 2008, a trademark application was filed for DIFFUSIO2N with the United States Patent and Trademark Office. The USPTO has given the DIFFUSIO2N trademark a serial number of 77577940. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 29, 2022. This trademark is owned by Diffusion Pharmaceuticals LLC. The DIFFUSIO2N trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
diffusio2n

General Information

Serial Number77577940
Word MarkDIFFUSIO2N
Filing DateWednesday, September 24, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 29, 2022
Registration Number4088239
Registration DateTuesday, January 17, 2012
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 6, 2009

Trademark Statements

Description of MarkThe mark consists of the letters and number in the following order with the "2" as a subscript: "Diffusio2n".
Goods and ServicesPharmaceuticals, namely, drugs that increase tissue oxygenation, drugs that assist with cancer treatment, drugs that increase tissue oxygenation that enhance performance of mammals
Pseudo MarkDIFFUSION TWO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"DIFFUSION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 29, 2022
Primary Code005
First Use Anywhere DateMonday, October 31, 2011
First Use In Commerce DateMonday, October 31, 2011

Trademark Owner History

Party NameDiffusion Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902
Party NameDiffusion Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902
Party NameDiffusion Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902

Trademark Events

Event DateEvent Description
Friday, July 29, 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, January 17, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 17, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, January 17, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 17, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 20, 2017TEAS SECTION 8 & 15 RECEIVED
Friday, December 15, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 15, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 17, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 17, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, December 10, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 9, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, December 9, 2011ASSIGNED TO LIE
Thursday, November 17, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 2, 2011STATEMENT OF USE PROCESSING COMPLETE
Monday, October 31, 2011USE AMENDMENT FILED
Monday, October 31, 2011TEAS STATEMENT OF USE RECEIVED
Wednesday, September 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2011SOU EXTENSION 5 GRANTED
Tuesday, August 30, 2011SOU EXTENSION 5 FILED
Tuesday, August 30, 2011TEAS EXTENSION RECEIVED
Tuesday, February 22, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, February 20, 2011SOU EXTENSION 4 GRANTED
Friday, February 18, 2011SOU EXTENSION 4 FILED
Friday, February 18, 2011TEAS EXTENSION RECEIVED
Saturday, August 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 13, 2010SOU EXTENSION 3 GRANTED
Monday, August 9, 2010SOU EXTENSION 3 FILED
Monday, August 9, 2010TEAS EXTENSION RECEIVED
Tuesday, April 20, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2010SOU EXTENSION 2 GRANTED
Wednesday, March 24, 2010SOU EXTENSION 2 FILED
Monday, April 19, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 24, 2010TEAS EXTENSION RECEIVED
Monday, August 31, 2009SOU EXTENSION 1 GRANTED
Monday, August 31, 2009SOU EXTENSION 1 FILED
Monday, August 31, 2009TEAS EXTENSION RECEIVED
Tuesday, March 31, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 6, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 17, 2008NOTICE OF PUBLICATION
Wednesday, December 3, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 3, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 3, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, December 3, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 3, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, December 3, 2008EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 2, 2008PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, December 1, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, November 14, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 13, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 10, 2008EXAMINER'S AMENDMENT ENTERED
Monday, November 10, 2008ASSIGNED TO LIE
Wednesday, October 29, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, October 29, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 29, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, October 29, 2008EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 29, 2008ASSIGNED TO EXAMINER
Tuesday, September 30, 2008NOTICE OF PSEUDO MARK MAILED
Monday, September 29, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

diffusio drugs tissue increase oxygenation enhance performance mammals treatment cancer pharmaceuticals